APA

Karp J. E., Blackford A., Smith B. D., Alino K., Seung A. H., Bolaños-Meade J., Greer J. M., Carraway H. E., Gore S. D., Jones R. J., Levis M. J., McDevitt M. A., Doyle L. A. & Wright J. J. (20100614). Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia. : Leukemia research.

Chicago

Karp Judith E, Blackford Amanda, Smith B Douglas, Alino Katrina, Seung Amy Hatfield, Bolaños-Meade Javier, Greer Jacqueline M, Carraway Hetty E, Gore Steven D, Jones Richard J, Levis Mark J, McDevitt Michael A, Doyle L Austin and Wright John J. 20100614. Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia. : Leukemia research.

Harvard

Karp J. E., Blackford A., Smith B. D., Alino K., Seung A. H., Bolaños-Meade J., Greer J. M., Carraway H. E., Gore S. D., Jones R. J., Levis M. J., McDevitt M. A., Doyle L. A. and Wright J. J. (20100614). Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia. : Leukemia research.

MLA

Karp Judith E, Blackford Amanda, Smith B Douglas, Alino Katrina, Seung Amy Hatfield, Bolaños-Meade Javier, Greer Jacqueline M, Carraway Hetty E, Gore Steven D, Jones Richard J, Levis Mark J, McDevitt Michael A, Doyle L Austin and Wright John J. Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia. : Leukemia research. 20100614.